Top Tweets for #GIMalignancies
@myESMO is not only science but also #networking
Dr Moez Mobarek was an observer with us in @Hospital_FJD at the #GIMalignancies and #PhaseIUnit
with an ESMO Palliative Care #fellowship
Great to see that the experience was helpful and brought him to #ESMO25 😊
#myESMOStory
Take home messages from the #ConVivir2025 today organised by @atuvibi @ACanPan and other #GIMalignancies patient advocacy groups
😰Most frequent symptom-fatigue
💊Systemic therapies-most frequent approach
🧬NGS still not always done
🧐Trials poorly understood
💪 Lets keep going
Incredibly grateful to @vineet_chopra & @CUDeptMedicine for highlighting our work on minimally invasive #Endoscopic resection techniques for #GImalignancies !
For full read 👉 https://t.co/6KE724LTWD
So grateful for @JChristieMD & @CUGastroHep for endless support 🙏
I’m so thrilled to preview and proof a copy of the @CUDeptMedicine 2025 Annual Report! It looks amazing - because our people and programs are just so!
Stay tuned for the full release of “Stronger Together!”
Exploring The Next Wave of Personalized Immuno-Oncology in GI Malignancies - @aditdharia
https://t.co/H9CgDPlHVS
#ImmunoOncology #Immunotherapy #ImmuneOnc #GIMalignancies #GIOncology #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
Join @YJanjigianMD, @DrShubhamPant & Dr. Strickler as they discuss treatment plans with HER2-targeted therapies for #GImalignancies & where these options fit in current guideline recommendations. 5/31 at 6:30 PM CDT at #ASCO24! With @PeerView & @CureCC: https://t.co/zPhARQtjgn
Remember to join us tonight, May 31 at 6:30 PM CDT, for our #GImalignancies in-person & virtual symposium, and to tweet your questions in advance! As always, please be sure to follow @PeerView for more #MedEd content! https://t.co/RmOXk4WqKa #ASCO24
Don't miss out on this #MedEd Seminars & Tumor Board on #GImalignancies on 5/31 at 6:30 PM CDT during #ASCO24! Featuring @YJanjigianMD, @DrShubhamPant, & John Strickler, MD, and produced with our partners @CureCC & @CCAlliance! #GIcancers https://t.co/RmOXk4WqKa
Join @YJanjigianMD, @DrShubhamPant & Dr. Strickler as they discuss treatment plans with HER2-targeted therapies for #GImalignancies & where these options fit in current guideline recommendations. 5/31 at 6:30 PM CDT at #ASCO24! With @PeerView & @CureCC: https://t.co/zPhARQtjgn
Comprehensive review from @GervasoLorenzo about Rationale of neoadjuvant immunotherapy in GI malignancies - @angelopirozzi3
#Cancer #FuturePerspectives #GIMalignancies #MayoClinic #Neoadjuvant #Immunotherapy #OncoDaily #Oncology
https://t.co/w2qfB5JDH1
🎯Comprehensive review from @GervasoLorenzo about
🟢Rationale of #neoadjuvantimmunotherapy in #GImalignancies
🟢completed trials in both #MSI-H and #MSS tumors
🟢Future perspectives
👇https://t.co/QQw7b8aDbp
#GIcancers #immunescape #NAT
Nice to see many engaged in additional cancer updates at Great Debates in GI Malignancies - @CathyEngMD
@YJanjigianMD @GreatDebatesCME
https://t.co/LkQp4UV9xW
#Cancer #CancerResearch #CancerUpdates #GIMalignancies #NYC #OncoDaily #Oncology
Join @YJanjigianMD, @DrShubhamPant & Dr. Strickler as they discuss treatment plans with HER2-targeted therapies for #GImalignancies & where these options fit in current guideline recommendations. 5/31 at 6:30 PM CDT at #ASCO24! @PeerView & @CCAlliance
https://t.co/Xln9L5K0y5
See the latest #GImalignancies live event from @PeerView @YJanjigianMD #ASCO24 #MedEd https://t.co/p8sfR8KyK4
Understand the evidence that supports biomarker testing and targeted therapies for the treatment of HER2+ #GImalignancies. With @YJanjigianMD, @DrShubhamPant, and John Strickler, MD on 5/31 during #ASCO24! Produced with @PeerView & @CCAlliance: https://t.co/Xln9L5K0y5
Join #GImalignancies experts @YJanjigianMD, @DrShubhamPant, and John Strickler, MD, on 5/31 at 6:30 PM CDT during #ASCO24 for a #MedEd Seminars & Tumor Board event, developed with our partners @CureCC & @CCAlliance! #GIcancers #MedTwitter https://t.co/RmOXk4WqKa
Join @YJanjigianMD, @DrShubhamPant & Dr. Strickler as they discuss treatment plans with HER2-targeted therapies for #GImalignancies & where these options fit in current guideline recommendations. 5/31 at 6:30 PM CDT at #ASCO24! With @CureCC & @CCAlliance: https://t.co/RmOXk4WqKa
Understand the evidence that supports biomarker testing and targeted therapies for the treatment of HER2+ #GImalignancies. 5/31 during #ASCO24 with @YJanjigianMD & John Strickler, MD! Produced with @CureCC & @CCAlliance: https://t.co/RmOXk4WqKa
In the latest episode of Oncology Overdrive: @MGHCancerCenter’s @aparna1024 talks with host @ShikhaJainMD about accessibility to screening for #GIoncology and #GImalignancies in the #globalhealthcare space.
Listen now: https://t.co/5bc3LVugnQ
'Targeting #KRAS has been one of the holy grails in #oncology'
@BenWestphalen, MD, @LMU_Muenchen gives us his thoughts on the progress made in targeting #KRAS in #GImalignancies 🎥
Find out more about the importance of #genomic #biomarkers in #mCRC 🗞️ 👉 https://t.co/ItCZUJRQrn
Excellent review by PhD Morelli at #ASCO23 about the landscape of immune bases approaches for #GImalignancies and how novel immune check point inhibitors could provide synergistic effect with PD1/PD-L1 and CTLA-4 inhibitors, without increased toxicity.😁👏
@ASCO
Last Seen Hashtags on Sotwe
izmittrv
Seen from Turkey
RandomChat
Seen from Netherlands
19años
Seen from Spain
CharcuteriaFina
Seen from United States
ngewebinor
Seen from United States
diyarbakırtravesti
Seen from Turkey
Zoophilia()
Seen from United Kingdom
foursome wife swap
Seen from Sweden
mnwo #gay
Seen from Germany
monkeyappleak
Seen from United States
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers